ABMT (ABMT) Stock Price & Analysis
ABMT (ABMT) rose 0.00% to USD 0 as of June 10, 2026 at 07:38 UTC, according to Nexqual real-time market data.
ABMT last closed at USD 0; the session ranged USD 0–0 on volume of 29,714 shares. Market capitalization is $35,452, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:38 UTC.
Key Statistics (as of June 10, 2026 at 07:38 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 29,714 shares |
| Market Cap | $35,452 |
| Exchange | PNK |
Technical Analysis (ABMT)
Nexqual's technical model rates ABMT "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 07:38 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ABMT)
Wall Street analysts rate ABMT "None", per Nexqual as of June 10, 2026 at 07:38 UTC.
| Consensus Rating | None |
|---|
Earnings (ABMT)
Source: Nexqual, June 10, 2026 at 07:38 UTC.
Financials & Fundamentals (ABMT)
| Total Revenue | $109,844 |
|---|---|
| Revenue Growth (YoY) | -81.30% |
| Gross Margin | +74.32% |
| Operating Margin | -62095.56% |
| Profit Margin | +0.00% |
| Current Ratio | 0.03 |
| Total Cash | $6,983 |
| Total Debt | $6.36M |
| Free Cash Flow | $428,306 |
Source: Nexqual, June 10, 2026 at 07:38 UTC.
Financial Health Score (ABMT)
Nexqual rates ABMT's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:38 UTC.
| Growth | Critical — Revenue -81% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $7K cash vs $6M debt |
| Cash Flow | Strong — FCF $428K, 390% margin |
| Efficiency | Mixed — No data |
Ownership (ABMT)
| Insider Ownership | +3.31% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 70.90M |
| Float | 68.24M |
Source: Nexqual, June 10, 2026 at 07:38 UTC.
Leadership (ABMT)
ABMT is led by Hui Wang (age 55), CEO, Controller & Director, per Nexqual as of June 10, 2026 at 07:38 UTC.
| CEO, Controller & Director | Hui Wang (age 55) |
|---|---|
| President, Treasurer, Compliance Officer & Director | Chi Ming Yu (age 51) |
| Secretary, CFO, COO & Director | Kai Gui (age 55) |
| Chairman of Scientific Board & Chief Medical Advisor of Greater China | Shangli Liu |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABTI | Alterola Biotech, Inc. | USD 0.01 | ▲ 0% |
| AAMTF | Armada Mercantile Ltd. | USD 0.22 | ▲ 0% |
| AASP | Agassi Sports Entertainment Cor | USD 6.98 | ▲ 11.68% |
| ABCP | AmBase Corp. | USD 0.25 | ▲ 0% |
| ABMBF | Abcourt Mines Inc. | USD 0.05 | ▼ 10% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:38 UTC. This page is informational and not investment advice.